• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Essilor receives AOA seal for UV absorbers/blockers

Article

Dallas-Essilor of America Inc. announced recently that the American Optometric Association (AOA) awarded its Seal of Acceptance for Ultraviolet Absorbers/ Blockers to Essilor's Varilux Airwear progressive lenses, along with its Ovation, Essilor Natural, and Adaptar progressive lenses made with Airwear material.

Dallas-Essilor of America Inc. announced recently that the American Optometric Association (AOA) awarded its Seal of Acceptance for Ultraviolet Absorbers/ Blockers to Essilor's Varilux Airwear progressive lenses, along with its Ovation, Essilor Natural, and Adaptar progressive lenses made with Airwear material.

The AOA's Seal of Acceptance for Ultraviolet Absorbers/Blockers is one of nine categories in the AOA Seal of Acceptance Program. The AOA's Commission on Ophthalmic Standards evaluates the quality of ophthalmic products, devices, and instruments. It specifies the minimum requirements and test procedures for acceptance of products for the AOA Seal of Acceptance for Ultraviolet Absorbers/Blockers.

"Essilor is thrilled to receive a Seal from the AOA for the second time. Select Airwear progressive lenses join Thin&Lite 1.67, which received the AOA Seal of Acceptance for Ultraviolet Absorbers/Blockers last year," said Carl Bracy, vice president of marketing for Essilor of America. "The Seal helps eye-care professionals assure patients that they are offering the best the industry has to offer."

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.